BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9535597)

  • 1. Clinical evaluation of random biopsy of urinary bladder in patients with superficial bladder cancer.
    Taguchi I; Gohji K; Hara I; Gotoh A; Yamada Y; Yamanaka K; Okada H; Arakawa S; Kamidono S
    Int J Urol; 1998 Jan; 5(1):30-4. PubMed ID: 9535597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of transurethral resection plus adjuvant intravesical chemotherapy for superficial bladder cancer.
    Nomi M; Gohji K; Okamoto M; Takenaka A; Ono Y; Fujii A
    Int J Urol; 1998 Nov; 5(6):534-9. PubMed ID: 9855120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate evaluation of factors affecting recurrence, progression, and survival in patients with superficial bladder cancer treated with intravesical bacillus Calmette-Guérin (Tokyo 172 strain) therapy: significance of concomitant carcinoma in situ.
    Takashi M; Wakai K; Hattori T; Furuhashi K; Ono Y; Ohshima S; Ohno Y
    Int Urol Nephrol; 2002; 33(1):41-7. PubMed ID: 12090337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of urothelial dysplasia concomitant with superficial bladder cancer].
    Ishii T; Takeuchi F; Hiratsuka Y; Ariyoshi A
    Nihon Hinyokika Gakkai Zasshi; 1999 Jun; 90(6):633-8. PubMed ID: 10422439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?
    Smith PJ; Lotan Y; Raj GV; Sagalowsky AI; Margulis V
    Cytopathology; 2014 Apr; 25(2):108-11. PubMed ID: 23551700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor.
    Palou J; Rodríguez-Rubio F; Huguet J; Segarra J; Ribal MJ; Alcaraz A; Villavicencio H
    J Urol; 2005 Sep; 174(3):859-61; discussion 861. PubMed ID: 16093970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of random mucosal biopsies in the management of superficial bladder cancer.
    Mufti GR; Singh M
    Eur Urol; 1992; 22(4):288-93. PubMed ID: 1490505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
    Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
    Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors.
    Herr HW; Pinsky CM; Whitmore WF; Sogani PG; Oettgen HF; Melamed MR
    Urology; 1985 Feb; 25(2):119-23. PubMed ID: 3881870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of multiple mucosal biopsies in new cases of superficial papillary bladder tumor].
    Kanamaru H; Shirahase T; Moroi S; Taniguchi T; Kuo JY; Okuno H; Kihara Y; Arai Y
    Hinyokika Kiyo; 1993 Feb; 39(2):127-30. PubMed ID: 8465685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The sensitivity and clinical implications of periodical bladder biopsy following transurethral resection of superficial bladder transitional cell carcinoma].
    Kanematsu A; Tsuji Y; Kanba H; Noguchi T; Kamoto T; Okabe T
    Hinyokika Kiyo; 2001 Jan; 47(1):1-4. PubMed ID: 11235213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic random bladder biopsies: reflections from a population-based cohort of 538 patients.
    Thorstenson A; Schumacher MC; Wiklund NP; Jonsson MN; Larsson P; Wijkström H; Onelöv E; Steineck G; De Verdier PJ
    Scand J Urol Nephrol; 2010 Feb; 44(1):11-9. PubMed ID: 19958071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.
    Herr HW; Pinsky CM; Whitmore WF; Sogani PC; Oettgen HF; Melamed MR
    J Urol; 1986 Feb; 135(2):265-7. PubMed ID: 3511284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapy.
    Saika T; Tsushima T; Nasu Y; Arata R; Kaku H; Kusaka N; Kumon H
    Jpn J Clin Oncol; 2002 Nov; 32(11):461-5. PubMed ID: 12499418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer.
    Kiemeney LA; Witjes JA; Heijbroek RP; Debruyne FM; Verbeek AL
    Eur J Cancer; 1994; 30A(11):1621-5. PubMed ID: 7833133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.